Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial
Raymond R. Townsend(University of Pennsylvania), Michael Böhm(Saarland University), Manesh R. Patel(Duke University), Kazuomi Kario(University of Pennsylvania), David P. Lee(APLA Health), Martin T. Rothman(Barts Health NHS Trust), Stuart Pocock(London School of Hygiene & Tropical Medicine), James W. Choi(Baylor Jack and Jane Hamilton Heart and Vascular Hospital), Sebastian Ewen(Schwarzwald-Baar Klinikum), Felix Mahfoud(University of Basel), Vanessa DeBruin(Medtronic (United States)), Michael A. Weber(SUNY Downstate Health Sciences University), Axel Schmid(Universitätsklinikum Erlangen), Roland E. Schmieder(Universitätsklinikum Erlangen), Debbie L. Cohen(University of Pennsylvania), George Dangas(Mount Sinai Hospital), Cara East(Baylor Jack and Jane Hamilton Heart and Vascular Hospital), Kiritkumar Patel, Martin Fahy(Medtronic (United States)), Konstantinos Tsioufis(National and Kapodistrian University of Athens), Neil Chapman, David E. Kandzari(Piedmont Atlanta Hospital), Philipp Lurz(Johannes Gutenberg University Mainz), Janice P. Lea, Jiro Aoki, Denise Jones(Medtronic (United States)), Ingrid Hopper(The Alfred Hospital), Chandan Devireddy, David Kandzari(Piedmont Atlanta Hospital), Karl Fengler(Leipzig Heart Institute), Shukri David(Piedmont Atlanta Hospital), Andrew S.P. Sharp, Justin E. Davies(Lung Institute), Robert Wilensky, A. Walton(The Alfred Hospital), Dimitrios Tousoulis(National and Kapodistrian University of Athens), Adrian Ma(Stanford Health Care), Anthony Watkinson(Royal Devon and Exeter Hospital), Sidney A. Cohen(University of Pennsylvania), Bryan Batson
Cited by 734
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k